Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements (English, HTML)

View metadata and access the original English HTML file: Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements.

Format

HTML

Access

file-only

Publisher-reported update

2021-05-28

Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.

Access original file